<annotation text="Abstract Glaucoma, a chronic progressive neuropathy and the most frequent cause of irreversible blindness worldwide, is commonly treated by medication or surgery aimed at lowering intraocular pressure. In view of the limited therapeutic options, the European Glaucoma Society (EGS) sponsored two Think Tank Meetings with the goal of assessing the current status and the overall perspectives for neuroprotective treatment strategies in glaucoma. The results of the meetings are summarized in this EGS White Paper.">
  <surfaceForm name="blindness" offset="96">
    <resource label="Blindness" uri="Blindness" contextualScore="0.9999314094330072" percentageOfSecondRank="2.1598741884586312E-8" support="2718" priorScore="2.260838437008358E-5" finalScore="0.9999999784012632" types="DBpedia:Disease"/>
  </surfaceForm>
  <surfaceForm name="goal" offset="325">
    <resource label="Goal" uri="Goal" contextualScore="0.9999997114583569" percentageOfSecondRank="1.4826069728648435E-8" support="954" priorScore="7.935393189499535E-6" finalScore="0.9999999802584514" types=""/>
  </surfaceForm>
  <surfaceForm name="neuropathy" offset="41">
    <resource label="Peripheral neuropathy" uri="Peripheral_neuropathy" contextualScore="0.9835673724141779" percentageOfSecondRank="2.1743655416007483E-5" support="839" priorScore="6.978820635209759E-6" finalScore="0.9999782568173461" types="DBpedia:Disease"/>
  </surfaceForm>
  <surfaceForm name="Society" offset="268">
    <resource label="Society" uri="Society" contextualScore="0.9997464532820397" percentageOfSecondRank="2.061033610168069E-5" support="4859" priorScore="4.041726992429585E-5" finalScore="0.9999787256416627" types=""/>
  </surfaceForm>
  <surfaceForm name="options" offset="237">
    <resource label="Option (finance)" uri="Option_(finance)" contextualScore="0.9994424109785229" percentageOfSecondRank="4.457032690403062E-7" support="1548" priorScore="1.287629838296151E-5" finalScore="0.9999992673356657" types=""/>
  </surfaceForm>
  <surfaceForm name="Glaucoma" offset="259">
    <resource label="Glaucoma" uri="Glaucoma" contextualScore="1.0" percentageOfSecondRank="0.0" support="759" priorScore="6.3133788583125236E-6" finalScore="1.0" types="DBpedia:Disease"/>
  </surfaceForm>
  <surfaceForm name="Meetings" offset="307">
    <resource label="Meeting" uri="Meeting" contextualScore="0.9700523712076725" percentageOfSecondRank="0.008791624646567832" support="474" priorScore="3.942742528116121E-6" finalScore="0.9912849608024644" types=""/>
  </surfaceForm>
  <surfaceForm name="therapeutic" offset="225">
    <resource label="Pharmaceutical drug" uri="Pharmaceutical_drug" contextualScore="0.900689659012228" percentageOfSecondRank="0.016995155388614812" support="3024" priorScore="2.5153699166715508E-5" finalScore="0.11497880424726278" types=""/>
    <resource label="Therapy" uri="Therapy" contextualScore="0.09691629621132804" percentageOfSecondRank="0.13021120082073884" support="1910" priorScore="1.58874224234215E-5" finalScore="0.883017770533839" types=""/>
  </surfaceForm>
  <surfaceForm name="surgery" offset="154">
    <resource label="Surgery" uri="Surgery" contextualScore="0.99992418311031" percentageOfSecondRank="1.6276635434923956E-8" support="6098" priorScore="5.072329944399179E-5" finalScore="0.9999999807252495" types=""/>
  </surfaceForm>
  <surfaceForm name="Think Tank" offset="296">
    <resource label="Think tank" uri="Think_tank" contextualScore="0.999999611140841" percentageOfSecondRank="1.3506331096002339E-9" support="2221" priorScore="1.8474327331109503E-5" finalScore="0.9999999985364525" types=""/>
  </surfaceForm>
  <surfaceForm name="progressive" offset="29">
    <resource label="Progressivism" uri="Progressivism" contextualScore="0.8003752723831525" percentageOfSecondRank="0.005822598439186542" support="1732" priorScore="1.4406814469825151E-5" finalScore="0.9879803554682439" types=""/>
  </surfaceForm>
  <surfaceForm name="medication" offset="140">
    <resource label="Pharmaceutical drug" uri="Pharmaceutical_drug" contextualScore="0.9488641806273393" percentageOfSecondRank="8.514887891734112E-4" support="3024" priorScore="2.5153699166715508E-5" finalScore="0.9991492327040631" types=""/>
  </surfaceForm>
  <surfaceForm name="perspectives" offset="378">
    <resource label="Perspective (cognitive)" uri="Perspective_(cognitive)" contextualScore="0.8303146609756893" percentageOfSecondRank="0.0860928221263729" support="208" priorScore="1.7301486199328126E-6" finalScore="0.8883697854844717" types=""/>
  </surfaceForm>
  <surfaceForm name="Abstract" offset="0">
    <resource label="Abstraction" uri="Abstraction" contextualScore="0.7736520716130902" percentageOfSecondRank="0.034525139911868986" support="626" priorScore="5.207081904220869E-6" finalScore="0.9610708993822997" types=""/>
  </surfaceForm>
  <surfaceForm name="treated" offset="129">
    <resource label="Therapy" uri="Therapy" contextualScore="0.9999999328228477" percentageOfSecondRank="2.855360353564131E-8" support="1910" priorScore="1.58874224234215E-5" finalScore="0.9999999476121402" types=""/>
  </surfaceForm>
  <surfaceForm name="limited" offset="217">
    <resource label="Limited series" uri="Limited_series" contextualScore="0.013451285225579413" percentageOfSecondRank="0.2160790248643521" support="2327" priorScore="1.9356037685498343E-5" finalScore="0.1076496342929277" types=""/>
    <resource label="Nuclear warfare" uri="Nuclear_warfare" contextualScore="0.2138897154384954" percentageOfSecondRank="0.3359902730734458" support="1568" priorScore="1.3042658827185818E-5" finalScore="0.3203950915251526" types=""/>
    <resource label="Limited government" uri="Limited_government" contextualScore="0.7216890620397697" percentageOfSecondRank="0.6179708608217104" support="188" priorScore="1.5637881757085038E-6" finalScore="0.5184631053624861" types=""/>
  </surfaceForm>
  <surfaceForm name="intraocular pressure" offset="180">
    <resource label="Intraocular pressure" uri="Intraocular_pressure" contextualScore="1.0" percentageOfSecondRank="0.0" support="168" priorScore="1.3974277314841948E-6" finalScore="1.0" types=""/>
  </surfaceForm>
  <surfaceForm name="White Paper" offset="500">
    <resource label="White paper" uri="White_paper" contextualScore="0.99980072718945" percentageOfSecondRank="3.96703397414015E-6" support="771" priorScore="6.413195124847109E-6" finalScore="0.999996031546148" types=""/>
  </surfaceForm>
  <surfaceForm name="chronic" offset="21">
    <resource label="Chronic pain" uri="Chronic_pain" contextualScore="0.9456289789586634" percentageOfSecondRank="5.1726704984185625E-5" support="339" priorScore="2.819809529602036E-6" finalScore="0.21296425482197595" types=""/>
    <resource label="Chronic (medicine)" uri="Chronic_(medicine)" contextualScore="0.05160948869399441" percentageOfSecondRank="0.27059562845205754" support="1119" priorScore="9.307866854350083E-6" finalScore="0.7870203079045959" types=""/>
  </surfaceForm>
  <surfaceForm name="EGS" offset="277">
    <resource label="European Graduate School" uri="European_Graduate_School" contextualScore="0.9639762586001508" percentageOfSecondRank="0.004885835923215999" support="130" priorScore="1.0813428874580078E-6" finalScore="0.9951377638290807" types="DBpedia:Agent, Schema:Organization, DBpedia:Organisation, Schema:EducationalOrganization, DBpedia:EducationalInstitution, Schema:CollegeOrUniversity, DBpedia:University"/>
  </surfaceForm>
  <surfaceForm name="assessing" offset="333">
    <resource label="Pain" uri="Pain" contextualScore="0.9999998990539944" percentageOfSecondRank="2.7657708437380317E-9" support="5493" priorScore="4.569089600620644E-5" finalScore="0.9999999972342266" types=""/>
  </surfaceForm>
  <surfaceForm name="commonly" offset="120">
    <resource label="Common name" uri="Common_name" contextualScore="0.9994512091645388" percentageOfSecondRank="0.0" support="3075" priorScore="2.5577918299487496E-5" finalScore="0.9999998098611694" types=""/>
  </surfaceForm>
  <surfaceForm name="frequent" offset="65">
    <resource label="Frequentative" uri="Frequentative" contextualScore="0.9831992145702143" percentageOfSecondRank="0.0" support="63" priorScore="5.24035399306573E-7" finalScore="0.9997112693421815" types=""/>
  </surfaceForm>
  <surfaceForm name="The" offset="445">
    <resource label="English articles" uri="English_articles" contextualScore="0.005524139704973018" percentageOfSecondRank="0.08915316225693903" support="5094" priorScore="4.237200514393148E-5" finalScore="0.4333270859376766" types=""/>
    <resource label="Joseph Stalin" uri="Joseph_Stalin" contextualScore="0.6949484338306458" percentageOfSecondRank="0.8207008499809738" support="6340" priorScore="5.273626081910593E-5" finalScore="0.5279963898510918" types="DBpedia:Agent, Schema:Person, Http://xmlns.com/foaf/0.1/Person, DBpedia:Person, DBpedia:OfficeHolder"/>
  </surfaceForm>
  <surfaceForm name="European" offset="250">
    <resource label="European Union" uri="European_Union" contextualScore="0.975670805922402" percentageOfSecondRank="9.55580161504174E-4" support="22919" priorScore="1.906407510588468E-4" finalScore="0.3296913618544397" types=""/>
    <resource label="Europe" uri="Europe" contextualScore="0.014078345101896787" percentageOfSecondRank="0.49224138846870713" support="73000" priorScore="6.072156214187275E-4" finalScore="0.6697757839503553" types="Schema:Place, DBpedia:Place, DBpedia:PopulatedPlace, Schema:Continent, DBpedia:Continent"/>
  </surfaceForm>
  <surfaceForm name="irreversible" offset="83">
    <resource label="Enzyme inhibitor" uri="Enzyme_inhibitor" contextualScore="0.9999982910977501" percentageOfSecondRank="1.569658000640846E-7" support="1116" priorScore="9.282912787716438E-6" finalScore="0.9999998379870039" types=""/>
  </surfaceForm>
  <surfaceForm name="worldwide" offset="106">
    <resource label="World" uri="World" contextualScore="0.9925441621324107" percentageOfSecondRank="1.7469580678516625E-5" support="2914" priorScore="2.4238716723481807E-5" finalScore="0.9999693120100752" types=""/>
  </surfaceForm>
  <surfaceForm name="In" offset="202">
    <resource label="Indium" uri="Indium" contextualScore="0.0043219281043372845" percentageOfSecondRank="0.18792057773449586" support="443" priorScore="3.6848838395684425E-6" finalScore="0.2816635587362501" types=""/>
    <resource label="Close vowel" uri="Close_vowel" contextualScore="0.819006854184767" percentageOfSecondRank="0.9512129130870447" support="145" priorScore="1.2061132206262397E-6" finalScore="0.29610989806913535" types=""/>
    <resource label="In.com" uri="In.com" contextualScore="0.17140627658663887" percentageOfSecondRank="0.8018905124188966" support="54" priorScore="4.491731994056341E-7" finalScore="0.3692647480962483" types="DBpedia:Agent, Schema:Organization, DBpedia:Organisation, DBpedia:Company"/>
  </surfaceForm>
  <surfaceForm name="glaucoma" offset="435">
    <resource label="Glaucoma" uri="Glaucoma" contextualScore="1.0" percentageOfSecondRank="4.3385997873236725E-24" support="759" priorScore="6.3133788583125236E-6" finalScore="1.0" types="DBpedia:Disease"/>
  </surfaceForm>
  <surfaceForm name="neuroprotective" offset="395">
    <resource label="Neuroprotection" uri="Neuroprotection" contextualScore="0.9999999999998295" percentageOfSecondRank="0.0" support="205" priorScore="1.7051945532991664E-6" finalScore="1.0" types=""/>
  </surfaceForm>
  <surfaceForm name="strategies" offset="421">
    <resource label="Strategy" uri="Strategy" contextualScore="0.9798750131632818" percentageOfSecondRank="1.1483511113908247E-4" support="1501" priorScore="1.2485351339034383E-5" finalScore="0.999820753075738" types=""/>
  </surfaceForm>
  <surfaceForm name="Glaucoma" offset="9">
    <resource label="Glaucoma" uri="Glaucoma" contextualScore="1.0" percentageOfSecondRank="0.0" support="759" priorScore="6.3133788583125236E-6" finalScore="1.0" types="DBpedia:Disease"/>
  </surfaceForm>
</annotation>